Click for best price
Inherited Metabolic Disorder Market Size, Share 2024
The global Inherited Metabolic Disorder market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Inherited Metabolic Disorder market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Inherited Metabolic Disorder market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Inherited Metabolic Disorder market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Enzyme Replacement Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Inherited Metabolic Disorder include Mayo Clinic, Angeion Corporation, Abbott U.S., Admera Health, Promega Corporation, Alomone Labs, Bio-Rad Laboratories, Novartis AG and AstaReal, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Inherited Metabolic Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inherited Metabolic Disorder. This report contains market size and forecasts of Inherited Metabolic Disorder in global, including the following market information:
Global Inherited Metabolic Disorder Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Inherited Metabolic Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inherited Metabolic Disorder Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Inherited Metabolic Disorder Market Segment Percentages, by Type, 2023 (%)
- Enzyme Replacement Therapy
- Cellular Transplantation
- Small Molecule Based Therapy
- Substrate Reduction Therapy
- Gene Therapy
- Drug Therapy
- Others
Global Inherited Metabolic Disorder Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Inherited Metabolic Disorder Market Segment Percentages, by Application, 2023 (%)
- Hurler Syndrome
- Niemann-Pick Disease
- Tay-Sachs Disease
- Gaucher Disease
- Fabry Disease
- Krabbe Disease
- Others
Global Inherited Metabolic Disorder Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Inherited Metabolic Disorder Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Inherited Metabolic Disorder revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Inherited Metabolic Disorder revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Mayo Clinic
- Angeion Corporation
- Abbott U.S.
- Admera Health
- Promega Corporation
- Alomone Labs
- Bio-Rad Laboratories
- Novartis AG
- AstaReal
- Regeneron Pharmaceuticals
- Biophytis
- AbbVie
- Danone
- Pfizer
- Bristol Myers Squibb
- Biogen
- GSK plc
- Roche Holding AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inherited Metabolic Disorder, market overview.
Chapter 2: Global Inherited Metabolic Disorder market size in revenue.
Chapter 3: Detailed analysis of Inherited Metabolic Disorder company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inherited Metabolic Disorder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Inherited Metabolic Disorder Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Inherited Metabolic Disorder Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inherited Metabolic Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inherited Metabolic Disorder Overall Market Size
2.1 Global Inherited Metabolic Disorder Market Size: 2023 VS 2030
2.2 Global Inherited Metabolic Disorder Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Inherited Metabolic Disorder Players in Global Market
3.2 Top Global Inherited Metabolic Disorder Companies Ranked by Revenue
3.3 Global Inherited Metabolic Disorder Revenue by Companies
3.4 Top 3 and Top 5 Inherited Metabolic Disorder Companies in Global Market, by Revenue in 2023
3.5 Global Companies Inherited Metabolic Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inherited Metabolic Disorder Players in Global Market
3.6.1 List of Global Tier 1 Inherited Metabolic Disorder Companies
3.6.2 List of Global Tier 2 and Tier 3 Inherited Metabolic Disorder Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Inherited Metabolic Disorder Market Size Markets, 2023 & 2030
4.1.2 Enzyme Replacement Therapy
4.1.3 Cellular Transplantation
4.1.4 Small Molecule Based Therapy
4.1.5 Substrate Reduction Therapy
4.1.6 Gene Therapy
4.1.7 Drug Therapy
4.1.8 Others
4.2 By Type - Global Inherited Metabolic Disorder Revenue & Forecasts
4.2.1 By Type - Global Inherited Metabolic Disorder Revenue, 2019-2024
4.2.2 By Type - Global Inherited Metabolic Disorder Revenue, 2025-2030
4.2.3 By Type - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inherited Metabolic Disorder Market Size, 2023 & 2030
5.1.2 Hurler Syndrome
5.1.3 Niemann-Pick Disease
5.1.4 Tay-Sachs Disease
5.1.5 Gaucher Disease
5.1.6 Fabry Disease
5.1.7 Krabbe Disease
5.1.8 Others
5.2 By Application - Global Inherited Metabolic Disorder Revenue & Forecasts
5.2.1 By Application - Global Inherited Metabolic Disorder Revenue, 2019-2024
5.2.2 By Application - Global Inherited Metabolic Disorder Revenue, 2025-2030
5.2.3 By Application - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Inherited Metabolic Disorder Market Size, 2023 & 2030
6.2 By Region - Global Inherited Metabolic Disorder Revenue & Forecasts
6.2.1 By Region - Global Inherited Metabolic Disorder Revenue, 2019-2024
6.2.2 By Region - Global Inherited Metabolic Disorder Revenue, 2025-2030
6.2.3 By Region - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Inherited Metabolic Disorder Revenue, 2019-2030
6.3.2 US Inherited Metabolic Disorder Market Size, 2019-2030
6.3.3 Canada Inherited Metabolic Disorder Market Size, 2019-2030
6.3.4 Mexico Inherited Metabolic Disorder Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Inherited Metabolic Disorder Revenue, 2019-2030
6.4.2 Germany Inherited Metabolic Disorder Market Size, 2019-2030
6.4.3 France Inherited Metabolic Disorder Market Size, 2019-2030
6.4.4 U.K. Inherited Metabolic Disorder Market Size, 2019-2030
6.4.5 Italy Inherited Metabolic Disorder Market Size, 2019-2030
6.4.6 Russia Inherited Metabolic Disorder Market Size, 2019-2030
6.4.7 Nordic Countries Inherited Metabolic Disorder Market Size, 2019-2030
6.4.8 Benelux Inherited Metabolic Disorder Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Inherited Metabolic Disorder Revenue, 2019-2030
6.5.2 China Inherited Metabolic Disorder Market Size, 2019-2030
6.5.3 Japan Inherited Metabolic Disorder Market Size, 2019-2030
6.5.4 South Korea Inherited Metabolic Disorder Market Size, 2019-2030
6.5.5 Southeast Asia Inherited Metabolic Disorder Market Size, 2019-2030
6.5.6 India Inherited Metabolic Disorder Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Inherited Metabolic Disorder Revenue, 2019-2030
6.6.2 Brazil Inherited Metabolic Disorder Market Size, 2019-2030
6.6.3 Argentina Inherited Metabolic Disorder Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Inherited Metabolic Disorder Revenue, 2019-2030
6.7.2 Turkey Inherited Metabolic Disorder Market Size, 2019-2030
6.7.3 Israel Inherited Metabolic Disorder Market Size, 2019-2030
6.7.4 Saudi Arabia Inherited Metabolic Disorder Market Size, 2019-2030
6.7.5 UAE Inherited Metabolic Disorder Market Size, 2019-2030
7 Inherited Metabolic Disorder Companies Profiles
7.1 Mayo Clinic
7.1.1 Mayo Clinic Company Summary
7.1.2 Mayo Clinic Business Overview
7.1.3 Mayo Clinic Inherited Metabolic Disorder Major Product Offerings
7.1.4 Mayo Clinic Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.1.5 Mayo Clinic Key News & Latest Developments
7.2 Angeion Corporation
7.2.1 Angeion Corporation Company Summary
7.2.2 Angeion Corporation Business Overview
7.2.3 Angeion Corporation Inherited Metabolic Disorder Major Product Offerings
7.2.4 Angeion Corporation Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.2.5 Angeion Corporation Key News & Latest Developments
7.3 Abbott U.S.
7.3.1 Abbott U.S. Company Summary
7.3.2 Abbott U.S. Business Overview
7.3.3 Abbott U.S. Inherited Metabolic Disorder Major Product Offerings
7.3.4 Abbott U.S. Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.3.5 Abbott U.S. Key News & Latest Developments
7.4 Admera Health
7.4.1 Admera Health Company Summary
7.4.2 Admera Health Business Overview
7.4.3 Admera Health Inherited Metabolic Disorder Major Product Offerings
7.4.4 Admera Health Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.4.5 Admera Health Key News & Latest Developments
7.5 Promega Corporation
7.5.1 Promega Corporation Company Summary
7.5.2 Promega Corporation Business Overview
7.5.3 Promega Corporation Inherited Metabolic Disorder Major Product Offerings
7.5.4 Promega Corporation Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.5.5 Promega Corporation Key News & Latest Developments
7.6 Alomone Labs
7.6.1 Alomone Labs Company Summary
7.6.2 Alomone Labs Business Overview
7.6.3 Alomone Labs Inherited Metabolic Disorder Major Product Offerings
7.6.4 Alomone Labs Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.6.5 Alomone Labs Key News & Latest Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Company Summary
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Inherited Metabolic Disorder Major Product Offerings
7.7.4 Bio-Rad Laboratories Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.7.5 Bio-Rad Laboratories Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Inherited Metabolic Disorder Major Product Offerings
7.8.4 Novartis AG Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.8.5 Novartis AG Key News & Latest Developments
7.9 AstaReal
7.9.1 AstaReal Company Summary
7.9.2 AstaReal Business Overview
7.9.3 AstaReal Inherited Metabolic Disorder Major Product Offerings
7.9.4 AstaReal Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.9.5 AstaReal Key News & Latest Developments
7.10 Regeneron Pharmaceuticals
7.10.1 Regeneron Pharmaceuticals Company Summary
7.10.2 Regeneron Pharmaceuticals Business Overview
7.10.3 Regeneron Pharmaceuticals Inherited Metabolic Disorder Major Product Offerings
7.10.4 Regeneron Pharmaceuticals Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.10.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.11 Biophytis
7.11.1 Biophytis Company Summary
7.11.2 Biophytis Business Overview
7.11.3 Biophytis Inherited Metabolic Disorder Major Product Offerings
7.11.4 Biophytis Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.11.5 Biophytis Key News & Latest Developments
7.12 AbbVie
7.12.1 AbbVie Company Summary
7.12.2 AbbVie Business Overview
7.12.3 AbbVie Inherited Metabolic Disorder Major Product Offerings
7.12.4 AbbVie Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.12.5 AbbVie Key News & Latest Developments
7.13 Danone
7.13.1 Danone Company Summary
7.13.2 Danone Business Overview
7.13.3 Danone Inherited Metabolic Disorder Major Product Offerings
7.13.4 Danone Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.13.5 Danone Key News & Latest Developments
7.14 Pfizer
7.14.1 Pfizer Company Summary
7.14.2 Pfizer Business Overview
7.14.3 Pfizer Inherited Metabolic Disorder Major Product Offerings
7.14.4 Pfizer Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.14.5 Pfizer Key News & Latest Developments
7.15 Bristol Myers Squibb
7.15.1 Bristol Myers Squibb Company Summary
7.15.2 Bristol Myers Squibb Business Overview
7.15.3 Bristol Myers Squibb Inherited Metabolic Disorder Major Product Offerings
7.15.4 Bristol Myers Squibb Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.15.5 Bristol Myers Squibb Key News & Latest Developments
7.16 Biogen
7.16.1 Biogen Company Summary
7.16.2 Biogen Business Overview
7.16.3 Biogen Inherited Metabolic Disorder Major Product Offerings
7.16.4 Biogen Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.16.5 Biogen Key News & Latest Developments
7.17 GSK plc
7.17.1 GSK plc Company Summary
7.17.2 GSK plc Business Overview
7.17.3 GSK plc Inherited Metabolic Disorder Major Product Offerings
7.17.4 GSK plc Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.17.5 GSK plc Key News & Latest Developments
7.18 Roche Holding AG
7.18.1 Roche Holding AG Company Summary
7.18.2 Roche Holding AG Business Overview
7.18.3 Roche Holding AG Inherited Metabolic Disorder Major Product Offerings
7.18.4 Roche Holding AG Inherited Metabolic Disorder Revenue in Global Market (2019-2024)
7.18.5 Roche Holding AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Inherited Metabolic Disorder Market Opportunities & Trends in Global Market
Table 2. Inherited Metabolic Disorder Market Drivers in Global Market
Table 3. Inherited Metabolic Disorder Market Restraints in Global Market
Table 4. Key Players of Inherited Metabolic Disorder in Global Market
Table 5. Top Inherited Metabolic Disorder Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Inherited Metabolic Disorder Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Inherited Metabolic Disorder Revenue Share by Companies, 2019-2024
Table 8. Global Companies Inherited Metabolic Disorder Product Type
Table 9. List of Global Tier 1 Inherited Metabolic Disorder Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inherited Metabolic Disorder Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Inherited Metabolic Disorder Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Inherited Metabolic Disorder Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Inherited Metabolic Disorder Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Inherited Metabolic Disorder Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Inherited Metabolic Disorder Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Inherited Metabolic Disorder Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Inherited Metabolic Disorder Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Inherited Metabolic Disorder Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Inherited Metabolic Disorder Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Inherited Metabolic Disorder Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Inherited Metabolic Disorder Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Inherited Metabolic Disorder Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Inherited Metabolic Disorder Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Inherited Metabolic Disorder Revenue, (US$, Mn), 2025-2030
Table 30. Mayo Clinic Company Summary
Table 31. Mayo Clinic Inherited Metabolic Disorder Product Offerings
Table 32. Mayo Clinic Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 33. Mayo Clinic Key News & Latest Developments
Table 34. Angeion Corporation Company Summary
Table 35. Angeion Corporation Inherited Metabolic Disorder Product Offerings
Table 36. Angeion Corporation Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 37. Angeion Corporation Key News & Latest Developments
Table 38. Abbott U.S. Company Summary
Table 39. Abbott U.S. Inherited Metabolic Disorder Product Offerings
Table 40. Abbott U.S. Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 41. Abbott U.S. Key News & Latest Developments
Table 42. Admera Health Company Summary
Table 43. Admera Health Inherited Metabolic Disorder Product Offerings
Table 44. Admera Health Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 45. Admera Health Key News & Latest Developments
Table 46. Promega Corporation Company Summary
Table 47. Promega Corporation Inherited Metabolic Disorder Product Offerings
Table 48. Promega Corporation Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 49. Promega Corporation Key News & Latest Developments
Table 50. Alomone Labs Company Summary
Table 51. Alomone Labs Inherited Metabolic Disorder Product Offerings
Table 52. Alomone Labs Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 53. Alomone Labs Key News & Latest Developments
Table 54. Bio-Rad Laboratories Company Summary
Table 55. Bio-Rad Laboratories Inherited Metabolic Disorder Product Offerings
Table 56. Bio-Rad Laboratories Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 57. Bio-Rad Laboratories Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Inherited Metabolic Disorder Product Offerings
Table 60. Novartis AG Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 61. Novartis AG Key News & Latest Developments
Table 62. AstaReal Company Summary
Table 63. AstaReal Inherited Metabolic Disorder Product Offerings
Table 64. AstaReal Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 65. AstaReal Key News & Latest Developments
Table 66. Regeneron Pharmaceuticals Company Summary
Table 67. Regeneron Pharmaceuticals Inherited Metabolic Disorder Product Offerings
Table 68. Regeneron Pharmaceuticals Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 69. Regeneron Pharmaceuticals Key News & Latest Developments
Table 70. Biophytis Company Summary
Table 71. Biophytis Inherited Metabolic Disorder Product Offerings
Table 72. Biophytis Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 73. Biophytis Key News & Latest Developments
Table 74. AbbVie Company Summary
Table 75. AbbVie Inherited Metabolic Disorder Product Offerings
Table 76. AbbVie Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 77. AbbVie Key News & Latest Developments
Table 78. Danone Company Summary
Table 79. Danone Inherited Metabolic Disorder Product Offerings
Table 80. Danone Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 81. Danone Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Inherited Metabolic Disorder Product Offerings
Table 84. Pfizer Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 85. Pfizer Key News & Latest Developments
Table 86. Bristol Myers Squibb Company Summary
Table 87. Bristol Myers Squibb Inherited Metabolic Disorder Product Offerings
Table 88. Bristol Myers Squibb Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 89. Bristol Myers Squibb Key News & Latest Developments
Table 90. Biogen Company Summary
Table 91. Biogen Inherited Metabolic Disorder Product Offerings
Table 92. Biogen Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 93. Biogen Key News & Latest Developments
Table 94. GSK plc Company Summary
Table 95. GSK plc Inherited Metabolic Disorder Product Offerings
Table 96. GSK plc Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 97. GSK plc Key News & Latest Developments
Table 98. Roche Holding AG Company Summary
Table 99. Roche Holding AG Inherited Metabolic Disorder Product Offerings
Table 100. Roche Holding AG Inherited Metabolic Disorder Revenue (US$, Mn) & (2019-2024)
Table 101. Roche Holding AG Key News & Latest Developments
List of Figures
Figure 1. Inherited Metabolic Disorder Segment by Type in 2023
Figure 2. Inherited Metabolic Disorder Segment by Application in 2023
Figure 3. Global Inherited Metabolic Disorder Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Inherited Metabolic Disorder Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Inherited Metabolic Disorder Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inherited Metabolic Disorder Revenue in 2023
Figure 8. By Type - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 9. By Application - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 10. By Type - Global Inherited Metabolic Disorder Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 12. By Application - Global Inherited Metabolic Disorder Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 14. By Region - Global Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 15. By Country - North America Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 16. US Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 20. Germany Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 21. France Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 28. China Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 32. India Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 34. Brazil Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Inherited Metabolic Disorder Revenue Market Share, 2019-2030
Figure 37. Turkey Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Inherited Metabolic Disorder Revenue, (US$, Mn), 2019-2030
Figure 41. Mayo Clinic Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Angeion Corporation Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Abbott U.S. Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Admera Health Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Promega Corporation Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Alomone Labs Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Bio-Rad Laboratories Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Novartis AG Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. AstaReal Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Regeneron Pharmaceuticals Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Biophytis Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. AbbVie Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Danone Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Pfizer Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Bristol Myers Squibb Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Biogen Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. GSK plc Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Roche Holding AG Inherited Metabolic Disorder Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
